drugset / Trial / NCT04849637

Virgin Coconut Oil as Adjunctive Therapy for Hospitalized COVID-19 Patients

NCT04849637 ↗

RandomizedParallel-groupSingle-blindTreatment

Summary

This is a research that will investigate the safety and efficacy of virgin coconut oil (VCO) as an adjunctive therapy for Coronavirus Disease 2019 (COVID-19)

Timeline

Start
2020-10-22
Primary completion
2022-04-09
Completion
2022-04-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Virgin Coconut Oil Unknown 15 ml Oral

Indications